BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 30124006)

  • 1. Synergistic Effect of Simvastatin and Romidepsin on Gamma-globin Gene Induction.
    Habibi H; Atashi A; Abroun S; Noruzinia M
    Cell J; 2019 Jan; 20(4):576-583. PubMed ID: 30124006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acyclovir induces fetal hemoglobin via downregulation of γ-globin repressors, BCL11A and SOX6 trans-acting factors.
    Ali H; Khan F; Ghulam Musharraf S
    Biochem Pharmacol; 2021 Aug; 190():114612. PubMed ID: 34010599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of γ/β Globin Gene Switching in CD 34
    Taghavi SA; Hosseini KM; Tamaddon G; Kasraian L
    Indian J Hematol Blood Transfus; 2019 Oct; 35(4):758-764. PubMed ID: 31741633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-30a regulates γ-globin expression in erythoid precursors of intermedia thalassemia through targeting BCL11A.
    Gholampour MA; Asadi M; Naderi M; Azarkeivan A; Soleimani M; Atashi A
    Mol Biol Rep; 2020 May; 47(5):3909-3918. PubMed ID: 32406020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tenofovir disoproxil fumarate-mediated γ-globin induction is correlated with the suppression of trans-acting factors in CD34
    Khan F; Ali H; Musharraf SG
    Eur J Pharmacol; 2022 Jul; 927():175036. PubMed ID: 35618038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease.
    Pule GD; Mowla S; Novitzky N; Wonkam A
    Clin Transl Med; 2016 Mar; 5(1):15. PubMed ID: 27056246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells.
    Macari ER; Schaeffer EK; West RJ; Lowrey CH
    Blood; 2013 Jan; 121(5):830-9. PubMed ID: 23223429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
    Ali H; Khan F; Musharraf SG
    Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using Clustered Regularly Interspaced Short Palindromic Repeats gene editing to induce permanent expression of fetal hemoglobin in β-thalassemia and sickle cell disease: A comparative meta-analysis.
    Quagliano A; Acevedo D; Hardigan P; Prasad S
    Front Med (Lausanne); 2022; 9():943631. PubMed ID: 36250099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease.
    Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M
    Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mRNA-Binding Protein IGF2BP1 Restores Fetal Hemoglobin in Cultured Erythroid Cells from Patients with β-Hemoglobin Disorders.
    Chambers CB; Gross J; Pratt K; Guo X; Byrnes C; Lee YT; Lavelle D; Dean A; Miller JL; Wilber A
    Mol Ther Methods Clin Dev; 2020 Jun; 17():429-440. PubMed ID: 32154328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.
    Wilber A; Hargrove PW; Kim YS; Riberdy JM; Sankaran VG; Papanikolaou E; Georgomanoli M; Anagnou NP; Orkin SH; Nienhuis AW; Persons DA
    Blood; 2011 Mar; 117(10):2817-26. PubMed ID: 21156846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenofovir disoproxil fumarate induces fetal hemoglobin production in K562 cells and β-YAC transgenic mice: A therapeutic approach for γ-globin induction.
    Khan F; Ali H; Musharraf SG
    Exp Cell Res; 2020 Sep; 394(2):112168. PubMed ID: 32653411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin induces FOXO3-dependent fetal hemoglobin production in human primary erythroid cells.
    Zhang Y; Paikari A; Sumazin P; Ginter Summarell CC; Crosby JR; Boerwinkle E; Weiss MJ; Sheehan VA
    Blood; 2018 Jul; 132(3):321-333. PubMed ID: 29884740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL11A Down-Regulation Induces γ-Globin in Human β-Thalassemia Major Erythroid Cells.
    Li J; Lai Y; Shi L
    Hemoglobin; 2018 Jul; 42(4):225-230. PubMed ID: 30821197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Erythroid Precursor Cells from β-Thalassemia Patients with
    Zuccato C; Cosenza LC; Zurlo M; Lampronti I; Borgatti M; Scapoli C; Gambari R; Finotti A
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic-screening generates active novel fetal globin-inducers that downregulate Bcl11a in a monkey model.
    Makino T; Haruyama M; Katayama K; Terashima H; Tsunemi T; Miyazaki K; Terakawa M; Yamashiro K; Yoshioka R; Maeda H
    Biochem Pharmacol; 2020 Jan; 171():113717. PubMed ID: 31751536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
    Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
    Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons.
    Rivers A; Vaitkus K; Jagadeeswaran R; Ruiz MA; Ibanez V; Ciceri F; Cavalcanti F; Molokie RE; Saunthararajah Y; Engel JD; DeSimone J; Lavelle D
    Exp Hematol; 2018 Nov; 67():60-64.e2. PubMed ID: 30125603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-365-3p mediates BCL11A and SOX6 erythroid-specific coregulation: A new player in HbF activation.
    Simbula M; Manchinu MF; Mingoia M; Pala M; Asunis I; Caria CA; Perseu L; Shah M; Crossley M; Moi P; Ristaldi MS
    Mol Ther Nucleic Acids; 2023 Dec; 34():102025. PubMed ID: 37744176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.